IL6 and cancer: But between the results obtained on murine cachexia models in different types of cancers, there are differences: in IL-6 mechanisms of action and in inhibition of various IL-6-dependent signaling pathways [68, 69] by attenuating or eradicating the progression of cachexia [67].